RxDoctor Payments Data

Timothy McGhee, MD

Family Medicine · Madisonville, KYNPI 1598800344

Payments from drug & device makers

$616in general payments, 2019–2025

Across 40 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$160
  • Amgen$58
  • GSK$53
  • AstraZeneca$47
  • Amarin Pharma, Inc.$41
  • Sanofi-aventis U.S. LLC$39
  • plus $218 from 10 others

What the payments were for

  • Food & beverage$52986%
  • Education$8714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$616 in reported general payments places this provider in the 45th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$172,733
Medicare patients
258
Services billed
3,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban172$147,121
JardianceEmpagliflozin154$133,033
OzempicSemaglutide65$74,532
EntrestoSacubitril/Valsartan49$45,686
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$32,471
Breztri AerosphereBudesonide/Glycopyr/Formoterol49$30,783
JanuviaSitagliptin Phosphate27$26,441
MounjaroTirzepatide22$23,880
TrulicityDulaglutide17$23,215
LinzessLinaclotide21$22,619
FarxigaDapagliflozin Propanediol18$21,863
Tresiba Flextouch U-200Insulin Degludec25$21,828
Breo ElliptaFluticasone/Vilanterol28$21,080
MyrbetriqMirabegron35$18,859
XareltoRivaroxaban15$13,797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$147,121172 claims
Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat$25$144,069177 claims
Novo NordiskOzempic$23$74,53265 claims
AstraZenecaBreztri Aerosphere, Farxiga, Brilinta, Symbicort$47$67,072105 claims
GSKTrelegy Ellipta, Breo Ellipta$53$53,55272 claims
Lilly USA, LLCMounjaro, Trulicity$33$47,09539 claims
AbbVieLinzess, Synthroid$34$26,70966 claims
Astellas Pharma US IncMyrbetriq$160$18,85935 claims
Johnson & JohnsonXarelto$12$13,79715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Madisonville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →